• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
AVTE

AVTE

Aerovate Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD2.68

+0.00 (+0.00%)

Company Profile

CEO

Timothy P. Noyes

IPO Date

2021-06-30

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$2.66

Prev. Close

$2.68

Day Low

$2.63

Day High

$2.77

52W Low

$2.63

52W High

$884.98

Market Cap

$0.08B

Volume

0.98M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

5

Avg Positive

15.8%

Avg Negative

1.8%

Avg Neutral

82.4%

News Feed

The 5 biggest insider stock buys of last week

Business Insider·7/12/2021·↓ negative

Aerovate Therapeutics Announces Closing of Initial Public Offering with Exercise in Full of the Underwriters' Option to Purchase Additional Shares

GlobeNewsWire·7/2/2021·↑ positive

Drug Formulation Developer Aerovate Therapeutics Kick Starts Trading Today With Upsized Debut

Benzinga
·6/30/2021
·↑ positive

Aerovate Therapeutics Announces Pricing of Upsized Initial Public Offering

GlobeNewsWire·6/29/2021·↑ positive

Aerovate Therapeutics Readies $100 Million IPO Effort

Seeking Alpha·6/28/2021·↑ positive